Published: 23 October 2020
Revised:  27 October 2020

Committees

Comments on agenda items for the 65th meeting of the Medicines Classification Committee to be held on 27 October 2020

The Medicines Classification Committee and the Secretary wish to thank everyone for their valuable input and feedback.

A total of 18 submissions commenting on agenda items for the 65th meeting was received (PDF,19.81 MB, 65 pages).

Agenda item 5.1.1 Reclassification of pholcodine – objection to the proposed recommendation that pholcodine be reclassified from a pharmacy-only medicine to a restricted medicine.

Seven comments were received about this agenda item.

Agenda item 5.2 Paracetamol – recommendation received from the coroner

Eleven comments were received about this agenda item.

Agenda item 6.1 Fexofenadine – proposed change to pack size limit and reclassification from pharmacy only to general sale

One comment was received about this agenda item.

Agenda item 6.2 Ibuprofen 400mg – proposed reclassification from restricted medicine to pharmacy only medicine

Two comments were received about this agenda item.

Agenda item 6.3 Flurbiprofen – proposed reclassification from pharmacy only medicine to general sale medicine

Two comments were received about this agenda item.

Agenda item 6.4 Hyoscine butylbromide – proposed addition of oral liquids in the current classification

One comment was received about this agenda item.

Agenda item 8.2.1.a Zolmitriptan

One comment was received about this agenda item.

Agenda item 8.2.1.b Mometasone

One comment was received about this agenda item.